MedTrace Logo

A Randomized Trial for Suicidal Patients

NCT02685943 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-04-19

No results posted yet for this study

Summary

Although suicide risk is highly prevalent among the patient population in mental health care, remarkably little research exists on effective treatments. Among a small set of novel approaches, CAMS is particularly promising. The investigators compare CAMS to TAU in a randomized controlled trial at four departments in Vestre Viken Hospital Trust, hypothesizing CAMS to be the superior approach. Primary outcome measures are suicidal ideation and suicide attempts, with secondary outcome measures including general symptoms of mental health problems. Changes in the outcome measures are compared between the two groups from baseline to 6 and 12 months after patients are included in the study. The study has the potential to impact the science of treating suicidal individuals and it could benefit the general public by establishing CAMS as an effective clinical approach for rapidly reducing suicide risk.

Conditions

Interventions

BEHAVIORAL

Psychotherapy

Sponsors & Collaborators

  • The Catholic University of America

    collaborator OTHER

  • Helse Sor-Ost

    collaborator OTHER_GOV

  • Norwegian Institute of Public Health

    collaborator OTHER_GOV

  • Vestre Viken Hospital Trust

    lead OTHER

Principal Investigators

  • Roar Fosse, Ph.D. · Division of mental health and addiction, Vestre Viken

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2019-04-01
Completion
2019-10-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02685943 on ClinicalTrials.gov